Pomalidomide (CC-4047) Evaluation Sample | 99.27% APEXBIO TECHNOLOGY LLC Immunomodulator,antumor/anti-angiogenic Apoptosis|TNF-α More Information Supplier Page × Pomalidomide (CC-4047)
Pomalidomide (CC-4047) 10mM (in 1mL DMSO) | 99.27% APEXBIO TECHNOLOGY LLC Immunomodulator,antumor/anti-angiogenic Apoptosis|TNF-α More Information Supplier Page × Pomalidomide (CC-4047)
Lenalidomide (CC-5013) 500mg | 98.66% APEXBIO TECHNOLOGY LLC Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α More Information Supplier Page × Lenalidomide (CC-5013)
Lenalidomide (CC-5013) 10mM (in 1mL DMSO) | 98.66% APEXBIO TECHNOLOGY LLC Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α More Information Supplier Page × Lenalidomide (CC-5013)
Lenalidomide (CC-5013) Evaluation Sample | 98.66% APEXBIO TECHNOLOGY LLC Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α More Information Supplier Page × Lenalidomide (CC-5013)
Lenalidomide (CC-5013) 50mg | 98.66% APEXBIO TECHNOLOGY LLC Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α More Information Supplier Page × Lenalidomide (CC-5013)
Lenalidomide (CC-5013) 100mg | 98.66% APEXBIO TECHNOLOGY LLC Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α More Information Supplier Page × Lenalidomide (CC-5013)
Lenalidomide (CC-5013) 250mg | 98.66% APEXBIO TECHNOLOGY LLC Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α More Information Supplier Page × Lenalidomide (CC-5013)
Bay 11-7821(BAY 11-7082) 100mg | 99.89% APEXBIO TECHNOLOGY LLC IKK/NF-κB/TNFα inhibitor Immunology/Inflammation|IκB/IKK More Information Supplier Page × Bay 11-7821(BAY 11-7082)
Bay 11-7821(BAY 11-7082) 50mg | 99.89% APEXBIO TECHNOLOGY LLC IKK/NF-κB/TNFα inhibitor Immunology/Inflammation|IκB/IKK More Information Supplier Page × Bay 11-7821(BAY 11-7082)